News
Recent studies revealed that Floratek’s new chemical entities exhibited picomolar activity in cancer cells
After meticulous SAR refinement through multiple rounds of chemical modifications the new generation of … Read more
Floratek Pharma is ranking 3rd in the most innovative Pharma SME in Switzerland
The recent innovation study was carried out by Swiss Institute for Quality Testing (SIQT), … Read more
Thrilled to announce new and very promising results
Floratek’s innovative approach to development of anti-cancer compounds has been rewarded with outstanding results … Read more